Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego J Maselli

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Multidisciplinary Respiratory Medicine|September 11, 2012
The need to further understand who gets hospitalized for a COPD exacerbationDiego J Maselli, Antonio Anzueto
Annals of Internal Medicine|November 20, 2018
Pooled RCTs: Adding LABAs to ICSs do not increase serious asthma events and reduce exacerbationsJay I Peters, Diego J Maselli
Annals of Internal Medicine|January 24, 2017
In refractory chronic cough, physiotherapy plus speech and language therapy improved quality of life at 4 weeksDiego J Maselli, Jay I Peters
Archivos De Bronconeumologia|May 3, 2024
Mortality Risk in BronchiectasisDiego J Maselli, Alejandro A Diaz
Pulmonary Therapy|November 21, 2025
Bronchiectasis Treatment Goals, Unmet Needs, and Emerging Therapies: A PodcastPatrick A Flume, Diego J Maselli
Annals of Internal Medicine|November 6, 2023
In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation levelRodolfo A Estrada, Diego J Maselli
Annals of Internal Medicine|June 16, 2015
ACP Journal Club. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthmaDiego J Maselli, Jay I Peters
Respiratory Care|May 26, 2018
Medication Regimens for Managing Acute AsthmaDiego J Maselli, Jay I Peters
Annals of Internal Medicine|June 19, 2018
Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbationsDiego J Maselli, Jay I Peters
Annals of Internal Medicine|October 20, 2017
In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 monthsDiego J Maselli, Jay I Peters
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Multidisciplinary Respiratory Medicine|September 11, 2012
The need to further understand who gets hospitalized for a COPD exacerbationDiego J Maselli, Antonio Anzueto
Annals of Internal Medicine|November 20, 2018
Pooled RCTs: Adding LABAs to ICSs do not increase serious asthma events and reduce exacerbationsJay I Peters, Diego J Maselli
Annals of Internal Medicine|January 24, 2017
In refractory chronic cough, physiotherapy plus speech and language therapy improved quality of life at 4 weeksDiego J Maselli, Jay I Peters
Archivos De Bronconeumologia|May 3, 2024
Mortality Risk in BronchiectasisDiego J Maselli, Alejandro A Diaz
Pulmonary Therapy|November 21, 2025
Bronchiectasis Treatment Goals, Unmet Needs, and Emerging Therapies: A PodcastPatrick A Flume, Diego J Maselli
Annals of Internal Medicine|November 6, 2023
In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation levelRodolfo A Estrada, Diego J Maselli
Annals of Internal Medicine|June 16, 2015
ACP Journal Club. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthmaDiego J Maselli, Jay I Peters
Respiratory Care|May 26, 2018
Medication Regimens for Managing Acute AsthmaDiego J Maselli, Jay I Peters
Annals of Internal Medicine|June 19, 2018
Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbationsDiego J Maselli, Jay I Peters
Annals of Internal Medicine|October 20, 2017
In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 monthsDiego J Maselli, Jay I Peters
Pageof 7